Identification of Factors Affecting Tacrolimus Level and 5-Year Clinical Outcome in Kidney Transplant Patients-Reference-Cited by-同舟云学术

Identification of Factors Affecting Tacrolimus Level and 5-Year Clinical Outcome in Kidney Transplant Patients

Published:2012-04 Issue: Volume: Page:n/a-n/a
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Kim In-Wha¹,Noh Hyejin¹,Ji Eunhee¹,Han Nayoung¹,Hong Su Hyun¹,Ha Jongwon²,Burckart Gilbert J.³,Oh Jung Mi¹

Affiliation:

1. College of Pharmacy and Research Institute of Pharmaceutical Sciences; Seoul National University; Seoul; Korea

2. Department of Surgery; Transplantation Research Institute; Seoul National University College of Medicine; Seoul; Korea

3. Office of Clinical Pharmacology; Office of Translational Sciences; Center for Drug Evaluation and Research; United States Food and Drug Administration; Silver Spring; MD; USA

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Reference39 articles.

1. Tacrolimus: a further update of its use in the management of organ transplantation;Scott;Drugs,2003

2. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation;Kershner;Transplantation,1996

3. An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group;Laskow;Transplantation,1996

4. Clinical pharmacokinetics of tacrolimus;Venkataramanan;Clin Pharmacokinet,1995

5. The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function;Mourad;Clin Chem Lab Med,2006

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intracellular tacrolimus concentration correlates with impaired renal function through regulation of the IS-AHR-ABC transporter in peripheral blood mononuclear cells;International Immunopharmacology;2024-01

2. Dosing strategies for de novo once-daily extended release tacrolimus in kidney transplant recipients based on CYP3A5 genotype;World Journal of Transplantation;2023-12-18

3. Multidrug resistant 1 (MDR1) C3435T and G2677T gene polymorphism: impact on the risk of acute rejection in pediatric kidney transplant recipients;Italian Journal of Pediatrics;2023-05-18

4. Intrapatient Variability (IPV) and the Blood Concentration Normalized by the Dose (C/D Ratio) of Tacrolimus—Their Correlations and Effects on Long-Term Renal Allograft Function;Biomedicines;2022-11-08

5. Organ Donation and Transplantation in Sub-Saharan Africa: Opportunities and Challenges;Organ Donation and Transplantation;2021-03-31